(NASDAQ:BLUE) traded lower for the fourth straight session as Bank of America and J.P. Morgan downgraded the gene therapy developer after its Q3 2024 results fell short of expectations for ...

Fintel reports that on November 14, 2024, JP Morgan initiated coverage of Blueprint Medicines (NasdaqGS:BPMC) with a ...

J.P. Morgan Chase is focused on supporting the growth of companies along the Front Range of the Rockies by advising on ...

JP Morgan initiated coverage on Blueprint Medicines Corporation (NASDAQ:BPMC), a biotech company focused on modulating immune ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 8.96% of ...

JPMorgan Chase & Co. Chief Executive Officer Jamie Dimon said companies will look harder at acquisitions in the wake of the ...

Jake Paul and Mike Tyson aren’t the only ones who have high stakes when they meet in the boxing ring on Friday night ...

Instructure is no longer trading on the New York Stock Exchange Headquartered in New York City, KKR was founded in 1976 Dragoneer has over $23 billion under management KKR and Dragoneer have closed ...

Orion Innovation ("Orion"), a leading digital transformation and product development services firm, today announced the ...

In a report released today, Mike Mayo from Wells Fargo maintained a Buy rating on JPMorgan Chase & Co. (JPM – Research Report), with ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 55.84% ...